Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

OBJECTIVE: To compare the effect of sitagliptin (100 mg) vs glimepiride (1–3 mg) as add-on therapy in Indian type 2 diabetes (T2DM) patients on treatment with insulin and metformin (SWIM study). RESEARCH DESIGN AND METHODS: This 24-week, controlled, open-label study randomized T2DM patients (n = 440...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Endocr Connect
Autori principali: Kesavadev, Jothydev, Pillai, Pradeep Babu Sadasivan, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
Natura: Artigo
Lingua:Inglês
Pubblicazione: Bioscientifica Ltd 2017
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5670271/
https://ncbi.nlm.nih.gov/pubmed/28982699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-17-0100
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi